NY | Jotup

Blink Charging Deploys 34 Electric Vehicle Chargers in the Village of Tuckahoe, New York

Retrieved on:

Tuesday, June 6, 2023

Village, Columbus Avenue, EV, AC, BLNK, Development, NY, Historic site, Recreation, Level 2, Depot Square Historic District (Randolph, Vermont), New York State Energy Research and Development Authority, Metro-North Railroad, Consolidated Edison, Growth, NYSERDA, Rail transport

Miami Beach, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announcement the deployment and installation of 34 chargers at eight locations throughout the Village of Tuckahoe, NY, building a significant EV charging infrastructure for the Village.

Key Points:

Miami Beach, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announcement the deployment and installation of 34 chargers at eight locations throughout the Village of Tuckahoe, NY, building a significant EV charging infrastructure for the Village.
“Electric vehicle adoption in the New York metropolitan area is strong, and additional infrastructure is needed to support growth.
Tuckahoe has demonstrated vision and forward thinking to meet the needs of EV drivers in the area,” said Michael Battaglia, Chief Revenue Officer for Blink Charging.
The charging stations support New York State’s goal of having 100% zero-emission passenger vehicle sales by 2035.

Tingo Group, Inc.’s Legal Counsel to Investigate Financial Institution Accused of Falsely Marketing an Equity Fundraise and Examine Unusual Stock Price Volatility

Retrieved on:

Thursday, June 1, 2023

Marketing, NY, TIO, Lawyer, Social media, USD, Cryptocurrency, Tingo District

For the avoidance of all doubt, the Company is not planning any placement, offering, or issuance of the Company’s equity securities.

Key Points:

For the avoidance of all doubt, the Company is not planning any placement, offering, or issuance of the Company’s equity securities.
For the avoidance of doubt, these export transactions do not require the Company to raise any equity funding.
Furthermore, the export business is expected to dollarize the entire amount of Tingo Group’s net income on a monthly basis by the end of 2023.
Legal Counsel are also now conducting a full investigation of any potential claims the Company may have against the NY Financial Institution and others in relation to the false marketing of an equity raise.

BioAtla to Participate in the Jefferies Healthcare Conference

Retrieved on:

Wednesday, May 31, 2023

Conditional, NY, Therapy, CAB, Conference, SAN, Pharmaceutical industry

SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will participate in a fireside chat and scheduled one-on-one investor meetings at the Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023.

Key Points:

SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will participate in a fireside chat and scheduled one-on-one investor meetings at the Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023.

Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference

Retrieved on:

Wednesday, May 31, 2023

NY, Conference, Fireside, Cryptocurrency, Pharmaceutical industry, Corbus

NORWOOD, Mass., May 31, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023.

Key Points:

NORWOOD, Mass., May 31, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023.
Management will also be available for one-on-one investor meetings during the conference.

Tyrone Cotie and Carl Gauvreau awarded FEI Canada's Highest Honour: The Frank S. Capon Distinguished Service Award

Retrieved on:

Tuesday, May 30, 2023

TORONTO, May 30, 2023 /CNW/ - Financial Executives International Canada (FEI Canada) is delighted to announce Tyrone Cotie from the Atlantic Chapter, and Carl Gauvreau from the Quebec Chapter, have been awarded FEI Canada's Highest Honour, The Frank S. Capon Distinguished Service Award for 2023.

Key Points:

TORONTO, May 30, 2023 /CNW/ - Financial Executives International Canada (FEI Canada) is delighted to announce Tyrone Cotie from the Atlantic Chapter, and Carl Gauvreau from the Quebec Chapter, have been awarded FEI Canada's Highest Honour, The Frank S. Capon Distinguished Service Award for 2023.
The Frank S. Capon Distinguished Service Award honours members who have contributed significantly to improving the organization throughout their career.
"The Quebec Chapter was thrilled to nominate Carl Gauvreau for this year's Frank S. Capon Distinguished Service Award.
"On behalf of the members and Board of Directors of FEI Canada, I'd like to congratulate Tyrone Cotie and Carl Gauvreau for being awarded the prestigious Frank S. Capon Distinguished Service Award.

MiX Telematics Announces Upcoming Investor Conference Schedule for May and June 2023

Retrieved on:

Thursday, May 25, 2023

Software, Technology, Fleet Management, Automotive, Fireside chats, NY, JSE, NYSE, TD, Conference, Lotte New York Palace Hotel, Cryptocurrency, MIX

MiX Telematics Limited (JSE: MIX) (NYSE: MIXT) (“MiX Telematics” or the “Company”), a leading global Software-as-a-Service (“SaaS”) provider of connected fleet management solutions, is scheduled to participate in the following upcoming investor conferences:

Key Points:

MiX Telematics Limited (JSE: MIX) (NYSE: MIXT) (“MiX Telematics” or the “Company”), a leading global Software-as-a-Service (“SaaS”) provider of connected fleet management solutions, is scheduled to participate in the following upcoming investor conferences:
TD Cowen 51st Annual Technology, Media & Telecom Conference
Location: Lotte New York Palace – New York, NY
Presentation: Wednesday, May 31st at 11:25 a.m.
ET
Location: Loews Chicago Hotel – Chicago, IL
Fireside Chat: Wednesday, June 7th at 4:40 p.m. CT
To receive additional information, request an invitation or to schedule a one-on-one meeting at either of these conferences, please contact your respective conference representative or the MiX Telematics’ investor relations team at [email protected] .

Avenge Bio to Participate in Upcoming Scientific & Investor Conferences

Retrieved on:

Wednesday, May 17, 2023

Rice University, Fallopian tube, Immunotherapy, Marriott Marquis, Doctor of Philosophy, ASCO, BCEC, NY, American Society of Clinical Oncology, Ovary, Annual general meeting, MA, Convention center, Boston Convention and Exhibition Center, Society, Conference, Pharmaceutical industry, Hotel, Patient

NATICK and QUINCY, Mass., May 17, 2023 /PRNewswire/ -- Avenge Bio, Inc. ("Avenge"), a clinical stage, oncology-focused biotechnology company developing the LOCOcyte™ Immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, today announced participation in the upcoming scientific and investor conferences:

Key Points:

NATICK and QUINCY, Mass., May 17, 2023 /PRNewswire/ -- Avenge Bio, Inc. ("Avenge"), a clinical stage, oncology-focused biotechnology company developing the LOCOcyte™ Immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, today announced participation in the upcoming scientific and investor conferences:
5th Annual Allogenic Cell Therapies Summit – May 22-25, 2023
Location: The Westin Boston Seaport District | Boston, MA
Presenter: Omid Veiseh, PhD (Rice University & Co-Founder, Avenge Bio)
American Society of Clinical Oncology (ASCO) Annual Meeting – June 2-6, 2023
Poster Title: A Phase 1/2 Open-Label, Multicenter, Dose Escalation, and Expansion Study of AVB-001, an Intraperitoneally Administered, Cell-Generated, Human IL-2 Immunotherapy in Patients with Platinum-Resistant, High-Grade, Serous Adenocarcinoma of the Ovary, Primary Peritoneum, or Fallopian Tube
BIO International Convention – June 5-8, 2023
Location: Boston Convention & Exhibition Center (BCEC) | Boston, MA
Members of the executive team will be participating in one-on-one partnering meetings.
To schedule a meeting, please submit a request via the partnering platform.
Jefferies Healthcare Conference – June 7-9, 2023
Location: Marriott Marquis | New York, NY | Track 3
Avenge will have an in-person presentation by Michael Heffernan, Chief Executive Officer.
Members of the executive team will be available to participate in one-on-one investor meetings.

Record-Breaking Comedians Gabriel “Fluffy” Iglesias and Taylor Tomlinson Headline National Comedy Center’s 2023 Lucille Ball Comedy Festival

Retrieved on:

Friday, May 5, 2023

The National Comedy Center , the nation’s official museum and cultural institution dedicated to comedy, announced today that comedians Gabriel “Fluffy” Iglesias and Taylor Tomlinson will headline the 2023 Lucille Ball Comedy Festival , August 2 through 6.

Key Points:

The National Comedy Center , the nation’s official museum and cultural institution dedicated to comedy, announced today that comedians Gabriel “Fluffy” Iglesias and Taylor Tomlinson will headline the 2023 Lucille Ball Comedy Festival , August 2 through 6.
Iglesias is the star and executive producer of the Netflix original comedy series Mr. Iglesias and numerous Netflix stand-up specials.
"I’m so excited to be a part of this summer’s Lucille Ball Comedy Festival in Jamestown, NY!” stated Taylor Tomlinson.
“It’s fitting that National Comedy Center’s festival will be headlined by both a legend of, and the future of, comedy.

MISTRAS Group to Participate in the Inaugural EF Hutton Global Conference on May 10, 2023

Retrieved on:

Friday, April 28, 2023

Inauguration, NY, MG, NYSE, Conference, Safety, Cryptocurrency, Lobster, Management

PRINCETON JUNCTION, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (MG: NYSE) – a leading “one source” multinational provider of technology-enabled asset protection solutions used to maximize the uptime and safety of critical energy, industrial, and public infrastructure – announced today that Dennis Bertolotti, President and Chief Executive Officer, and Edward Prajzner, Chief Financial Officer, will be attending the Inaugural EF Hutton Global Conference, being held from May 10-11, 2023 in New York, NY – USA.

Key Points:

PRINCETON JUNCTION, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (MG: NYSE) – a leading “one source” multinational provider of technology-enabled asset protection solutions used to maximize the uptime and safety of critical energy, industrial, and public infrastructure – announced today that Dennis Bertolotti, President and Chief Executive Officer, and Edward Prajzner, Chief Financial Officer, will be attending the Inaugural EF Hutton Global Conference, being held from May 10-11, 2023 in New York, NY – USA.
Management will be available for one-on-one meetings on Wednesday, May 10.

Monarch Private Capital Hires Kalpana Sahajwani as Manager, Asset Management

Retrieved on:

Friday, April 28, 2023

Asset management, ERCOT, University, Rice University, PJM, Electricity, MBA, MS, NY, Monarch, Cryptocurrency, Kalpana, C02

ATLANTA, April 28, 2023 (GLOBE NEWSWIRE) -- Monarch Private Capital , a nationally recognized impact investment firm that develops, finances and manages a diversified portfolio of projects that generate both federal and state tax credits, is pleased to welcome Kalpana Sahajwani as Manager, Asset Management.

Key Points:

ATLANTA, April 28, 2023 (GLOBE NEWSWIRE) -- Monarch Private Capital , a nationally recognized impact investment firm that develops, finances and manages a diversified portfolio of projects that generate both federal and state tax credits, is pleased to welcome Kalpana Sahajwani as Manager, Asset Management.
Sahajwani is highly skilled in asset optimization, valuation of renewable power acquisitions and development opportunities in US and international markets.
“The addition of Kalpana to Monarch’s asset management team deepens its breadth of expertise, better positioning the firm to capitalize on the expected growth opportunities in this post-IRA climate,” said Emily DiCenso , Managing Director, Asset Management at Monarch.
For more information on Monarch Private Capital and its ESG-oriented impact investment funds, please contact Brent Barringer by emailing [email protected] .